European startups in remote monitoring attract record funding

Business Insider reports (in Spanish) on the remote monitoring devices that define the new frontier of medical innovations. 13 startups poised to take off, according to investors, are presented. Whether it’s chronic disease management or respiratory conditions, remote monitoring technology helps clinicians monitor their patients’ health and progress outside of the clinic. To ensure that health personnel are not overwhelmed, some hospital appointments can be attended remotely, providing doctors with real-time data. Data from Dealroom shows that European startups focusing on remote monitoring and wearable health tech raised €1.122 billion in 2021, more so in 2022 is expected.

The report by the Business Insider covers the 13 startups, that are involved with the following projects:

  • a bracelet to track fertility, based on various health data sources
  •  a wearable fertility tracking device that measures carbon dioxide levels in people’s breath to assess their fertility cycles
  • virtual reality glasses that convert brain waves into commands (brings EEG software home)
  • medical devices for discharged patients that allow hospitals to follow-up remotely
  • devices for pelvic floor health and a hands-free breast pump
  • smart insoles that collect biometric data from the movement of the foot to prevent injury while jogging
  • a smart ring that tracks heart rate, temperature, blood oxygen, and sleep
  • a headband that uses transcranial electrical stimulation to alter the way users experience pain and mood swings
  • a cube-shaped device that allows users to measure heart rate, heart sound, and respiration rate and variability, at a distance of up to 7 meters
  • a rectangular device to be carried on backs, shoulders, helmets or headphones, that in real time alerts of any movements it deems harmful based on its AI vision processing technology
  • an API for all health apps in Europe, that will allow to harness all user’s health data
  • at-home blood test that also determines cholesterol levels and vitamin deficiencies
  • a surface chip that alerts of the sudden increase in the stress hormone in body sweat 

Related News

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner

Biomedical Innovations Awarded in Brazil

“Those who innovate to transform lives deserve an award” is the motto of the SBEB-Boston Scientific Award for Innovation in Biomedical Engineering, which encourages the

All News

Willum Þór: The question remains if our healthcare system is sustainable

On January 1st, Iceland took over the Presidency of the Nordic Council of Ministers. This intergovernmental organisation plays an important role in promoting innovations, health data integration, and cooperation between all major stakeholders in the Nordic healthcare. The Icelandic Health Minister elaborates on his vision to future health in the Nordic region, the Nordic strengths, Iceland’s plans for the Presidency with regards to health innovations, and the coming collaboration with Copenhagen Institute for Futures Studies

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner